To whom must the collaborative agreement be submitted?

To whom must the collaborative agreement be submitted?

• A. Board and BME
• B. Board only
• C. BME only
• D. No submission required

Answer: (A)

In Montana, a collaborative practice agreement between a pharmacist and a prescriber must be filed with both governing boards—the Board of Pharmacy and the Board of Medical Examiners. This dual submission ensures that the agreement is reviewed and recorded by the board that licenses pharmacists and by the board that licenses physicians, aligning the pharmacist’s prescriptive authority with medical oversight and regulatory requirements. Submitting to both boards provides formal acknowledgment and accountability from each side of the collaboration, helps define the scope of the pharmacist’s authority within the medical team, and ensures ongoing compliance with the rules governing both professions. If the agreement were submitted to only one board, the other board would remain unaware of the arrangement, which could create regulatory gaps and potential noncompliance. Not submitting at all would be noncompliant with state requirements. So the best choice is that the collaborative agreement must be submitted to both the Board of Pharmacy and the Board of Medical Examiners.

In Montana, a collaborative practice agreement between a pharmacist and a prescriber must be filed with both governing boards—the Board of Pharmacy and the Board of Medical Examiners. This dual submission ensures that the agreement is reviewed and recorded by the board that licenses pharmacists and by the board that licenses physicians, aligning the pharmacist’s prescriptive authority with medical oversight and regulatory requirements.

Submitting to both boards provides formal acknowledgment and accountability from each side of the collaboration, helps define the scope of the pharmacist’s authority within the medical team, and ensures ongoing compliance with the rules governing both professions. If the agreement were submitted to only one board, the other board would remain unaware of the arrangement, which could create regulatory gaps and potential noncompliance. Not submitting at all would be noncompliant with state requirements.

So the best choice is that the collaborative agreement must be submitted to both the Board of Pharmacy and the Board of Medical Examiners.